Immunogenicity of meningococcus C vaccination in a patient with atypical hemolytic uremic syndrome (aHUS) on eculizumab therapy. [electronic resource]
Producer: 20130110Description: E246-50 p. digitalISSN:- 1399-3046
- Antibodies -- chemistry
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Atypical Hemolytic Uremic Syndrome
- Child
- Complement Factor H -- genetics
- Complement Inactivating Agents -- pharmacology
- Hemolytic-Uremic Syndrome -- complications
- Heterozygote
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney Transplantation -- methods
- Male
- Meningococcal Infections -- immunology
- Meningococcal Vaccines -- immunology
- Mutation
- Mycophenolic Acid -- analogs & derivatives
- Neisseria meningitidis -- metabolism
- Peritoneal Dialysis
- Recurrence
- Renal Insufficiency -- therapy
- Steroids -- therapeutic use
- Tacrolimus -- therapeutic use
- Time Factors
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.